[{"data":1,"prerenderedAt":277},["ShallowReactive",2],{"story-23677-cn":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":50,"questions":51,"relatedArticles":64,"body_color":275,"card_color":276},"23677",null,"Pharma Trends: E-Commerce Opportunities in Healthcare Innovation","- $300B Market Shift Creates New Seller Strategies for 2024-2025",[],[10,11,12,13,14,13,15,16,17,18,13,19,20,21,22,23,24,25,26,27,28,29,30,31,13,19,32,33,34,35,36,37,38,39,40,41,42,12,43,44,45,46,47,48,49,36],"https://c.firstwordpharma.com/firstwordgroup/assets/adobe/images/misc_san_francisco.jpeg","https://imgproxy.divecdn.com/FbaAEg062_F_efXokPmdHTwKzgzkqPhw0RwLKhzKFmQ/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWEtaWxsdXN0cmF0aW9uLUpQTV9jb25mZXJlbmNlXzAxMDYyMF8yLnBuZw==.webp","https://www.modernhealthcare.com/resizer/v2/NQAEZBZY6BGAXA62UZ25AYKJ3I.png?smart=true&auth=730a0982605eb519f3490c11a0b2bdc99a7d1c4a29819aab2c95a12e435dcf0b&width=1600&height=900","https://www.geneonline.com/wp-content/uploads/%E4%B8%80%E6%9C%88-450x350-Banner-E.jpg","https://us-west-2-biocentury.graphassets.com/AqjgGpburRt67lm6SEY2Oz/cmkbu39v7rvgx07lp785w4bsm","https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20260109/0-81b9306ae8882db6d847c0513b21c9ee-0-af308161e287feea59afc30e3d30e4e9.png/big","https://cdn.abcotvs.com/dip/images/18394381_011226-kgo-jp-health-conference-img.jpg","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-2227847017.jpg?VersionId=W.ZMonlukL3cl65yikzzpddEgf7P1Y1H","https://s.yimg.com/ny/api/res/1.2/l0Dw73ZNbUsdCBll1fOHYw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/pharmaceutical_technology_376/7dd00716f2098141cc75893800af0285","https://www.geneonline.com/wp-content/uploads/EN_Mobile_Dec_HIV_AIDS-450x350.png","https://imgproxy.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/18907541/9cdmp5/ALTERNATES/master-3_2/jp-morgan","https://endpoints.news/wp-content/uploads/2026/01/JPM26_day_01_fi.jpg","https://www.statnews.com/wp-content/uploads/2026/01/JPM_26_illo_v2-645x645.jpg","https://img-s-msn-com.akamaized.net/tenant/amp/entityid/AA1TU4y6.img?w=768&h=512&m=6","https://i0.wp.com/news.biobuzz.io/wp-content/uploads/2026/01/Biotech-upswing.png?fit=998%2C875&ssl=1&w=640","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1952305259.jpg?VersionId=2ARrSF3vx04BhYsgiBcNkAIUx6gxz5fB","https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/jpmorgan-logo-hong-kong-logo-sunset-updated.jpg?VersionId=OYGrqXD_s4DK06Lkzk.lIPyf9p.JmP2p","https://s.tradingview.com/static/images/illustrations/news-story.jpg","https://www.evaluate.com/wp-content/uploads/2026/01/img_post_report_daily_update_purple.webp","https://www.reuters.com/resizer/v2/DD2WGYYDCFITTCCRHNYKPZVC5I.jpg?auth=0d8bb9f44dcecfa3c7163b53752ffee535773ebeb213e2c1e2ceb0abedd0c2d7&height=1920&width=1920&quality=80&smart=true","https://s.yimg.com/os/en/reuters.com/753b31989bb885c77e11b66781eb9786","https://ts2.tech/wp-content/uploads/2026/01/healthcare-stocks-face-jpmorgan-conference-pressure-as-xlv-slips-and-deal-talk-builds-featured.jpg","https://c.firstwordpharma.com/firstwordgroup/assets/adobe/images/money_100_dollar_bills_falling.jpeg","https://assets.sfstandard.com/image/994911177489/image_n103u6i7tp5f77g847ofgjp61f/-S3840x2560-FPNG","https://www.geneonline.com/wp-content/uploads/Screenshot-2026-01-08-173133.png","https://www.devdiscourse.com/remote.axd?https://devdiscourse.blob.core.windows.net/aiimagegallery/09_09_2025_12_05_11_566197.png?width=1280","https://images.barrons.com/im-36451541?width=700&height=466","https://www.geneonline.com/wp-content/uploads/%E4%B8%80%E6%9C%88-750x750-Banner-E-450x350.jpg","https://www.statnews.com/wp-content/uploads/2022/06/AdamsTake_Illustration_MollyFerguson_061322-645x645.jpg","https://www.genengnews.com/wp-content/uploads/2026/01/AdobeStock_99491899-1392x974-1.jpeg","https://media.bizj.us/view/img/13118936/pxl20260108001840810*900xx4000-2247-0-0.jpg","https://www.bioworld.com/ext/resources/Stock-images/Money/Businesswoman-pressing-dollar-sign-on-touch-screen-.webp?t=1620853996","https://cf-images.us-east-1.prod.boltdns.net/v1/jit/1265527929001/b279a006-1cee-441a-9b82-a1194ee40756/main/1280x720/40s117ms/match/image.jpg","https://image.cnbcfm.com/api/v1/image/108222520-17624504352025-11-06t173326z_182594845_rc24rhaozaeo_rtrmadp_0_usa-trump.jpeg?v=1767995336&w=1600&h=900","https://s7d1.scene7.com/is/image/CENODS/JPM-day-one---317997?$responsive$&qlt=90,0&resMode=sharp2&fmt=webp","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iO4jnVZ3aXTw/v0/-1x-1.webp","https://static.biospace.com/dims4/default/5580429/2147483647/strip/true/crop/1254x706+0+65/resize/1000x563!/quality/90/?url=https%3A%2F%2Fstatic.biospace.com%2F8f%2Fe6%2F161bc323476ca3f9a6ea303db160%2Fistock-2232417355.jpg","https://biz.chosun.com/resizer/v2/63SLWUUGEZAXLIRQU4NLMU2LEY.png?auth=2faca7d454e1ef348e4a3504820943c1ae2a9e43208bc13e2f9a1f290c3d9983&width=1186&height=622&smart=true","https://endpoints.news/wp-content/uploads/2026/01/JPM26_day_02_fi.jpg","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iNmQ2pbAw8Oo/v6/1200x798.jpg","**The 2026 JPMorgan Healthcare Conference reveals critical market transformation opportunities for cross-border e-commerce sellers in the pharmaceutical and wellness sectors.**\n\nThe pharmaceutical landscape is experiencing unprecedented disruption, presenting strategic entry points for digital sellers across multiple product categories. **Key market signals indicate a $300 billion patent expiration cycle**, creating significant opportunities in generic medications, wellness products, and emerging therapeutic markets.\n\n**Obesity and Weight Management Segment Expansion**\nThe GLP-1 medication market represents a breakthrough opportunity for e-commerce sellers. Companies like Novo Nordisk and Eli Lilly are pioneering innovative weight loss solutions, signaling massive consumer demand. Sellers should strategically position themselves in complementary product categories:\n- Nutritional supplements\n- Fitness tracking devices\n- Wellness apparel and accessories\n- Specialized dietary products\n\n**Pharmaceutical Patent Landscape Shifts**\nMajor drug patent expirations, including blockbuster medications like Eliquis and Keytruda, will create substantial market volatility. This presents unique opportunities for sellers to:\n- Develop generic medication support products\n- Create complementary wellness solutions\n- Target emerging patient demographics\n- Leverage digital marketing for niche therapeutic markets\n\nStrategic sellers can capitalize on these transitions by:\n1. Developing targeted product bundles\n2. Creating content-driven marketing strategies\n3. Exploring cross-border marketplace expansion\n4. Investing in specialized healthcare product lines\n\nThe conference underscores a critical insight: healthcare innovation is no longer confined to traditional medical channels but increasingly intersects with digital commerce, creating unprecedented opportunities for agile, strategic sellers.",[52,55,58,61],{"title":53,"answer":54,"author":5,"avatar":5,"time":5},"How can e-commerce sellers capitalize on pharmaceutical market changes?","Sellers can develop complementary wellness products, create targeted marketing for emerging patient demographics, and explore specialized healthcare product lines aligned with patent expirations and new medication trends.",{"title":56,"answer":57,"author":5,"avatar":5,"time":5},"How significant is the patent expiration market opportunity?","The $300 billion patent expiration cycle represents a massive market restructuring, creating opportunities for generic medication support products and innovative wellness solutions across multiple digital platforms.",{"title":59,"answer":60,"author":5,"avatar":5,"time":5},"What product categories show the most promise in healthcare e-commerce?","Nutritional supplements, fitness tracking devices, specialized dietary products, and wellness accessories related to weight management and chronic condition support are showing significant growth potential.",{"title":62,"answer":63,"author":5,"avatar":5,"time":5},"What strategic approaches should sellers consider in healthcare e-commerce?","Develop content-driven marketing, create product bundles, explore cross-border marketplace expansion, and invest in specialized healthcare product lines that complement emerging medical innovations.",[65,70,75,79,83,87,91,95,100,104,108,113,117,121,125,129,133,137,141,145,149,153,157,161,165,168,172,177,181,185,189,193,197,201,205,209,213,217,221,225,229,233,237,241,245,249,253,257,260,264,268,271],{"id":66,"title":67,"source":68,"logo":5,"time":69},225249,"Live from JPM Healthcare Conference: Highlights from San Francisco","https://www.mmm-online.com/news/live-from-jpm-healthcare-conference-highlights-from-san-francisco-2026/","4天前",{"id":71,"title":72,"source":73,"logo":20,"time":74},225248,"Investors look forward to agenda-setting conference: “The dialogues are already underway”","https://medwatch.com/News/Pharma___Biotech/article18908900.ece","5天前",{"id":76,"title":77,"source":78,"logo":22,"time":69},225247,"On Day 1 of JPM, no blockbuster headlines, but biotech newsmakers still move markets","https://www.statnews.com/2026/01/12/jpm-2026-day-1-top-stories-bridgebio-moderna-eli-lilly-readout-newsletter/",{"id":80,"title":81,"source":82,"logo":34,"time":74},225253,"J2026 .P. Morgan Healthcare Conference","https://www.geneonline.com/events/j-p-morgan-healthcare-conference/",{"id":84,"title":85,"source":86,"logo":19,"time":74},225252,"JP Morgan Healthcare Conference Highlights Networking and Industry Insights Without Defining Biotech Success","https://www.geneonline.com/jp-morgan-healthcare-conference-highlights-networking-and-industry-insights-without-defining-biotech-success/",{"id":88,"title":89,"source":90,"logo":39,"time":74},225251,"StockWatch@JPM: EY Sees M&A Surging, IPOs Sluggish in 2026","https://www.genengnews.com/insights/trends-for-2026/stockwatchjpm-ey-sees-ma-surging-ipos-sluggish-in-2026/",{"id":92,"title":93,"source":94,"logo":36,"time":69},225250,"‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News.","https://www.barrons.com/articles/biotech-stocks-chase-conference-b9cab762?gaa_at=eafs&gaa_n=AWEtsqdjUTgXy0hrfWXVwKmNVnezUevoibINnd6j_EaoHKEmydJ_KGkzlqyc&gaa_ts=6966388f&gaa_sig=FUkmOzpfF6aZcsRkrvqZb6wIOnTsQS57ueSfyjQkTJamiew3vY6N_4JvO2P2cFiciXQl8S28VbxBiLIo4nyeIw%3D%3D",{"id":96,"title":97,"source":98,"logo":32,"time":99},225257,"Vital Signs: Where's the party at? Your JPM events breakdown","https://www.firstwordpharma.com/story/7055524","6天前",{"id":101,"title":102,"source":103,"logo":24,"time":99},225256,"Navigating JPM Healthcare Week: Biotech's New Growth Cycle","https://news.biobuzz.io/2026/01/10/the-case-for-a-multi-year-biotech-upswing-leading-analysts-read-on-the-market-ahead-of-jpm-week/",{"id":105,"title":106,"source":107,"logo":31,"time":99},225255,"Healthcare stocks face JPMorgan conference pressure as XLV slips and deal talk builds","https://ts2.tech/en/healthcare-stocks-face-jpmorgan-conference-pressure-as-xlv-slips-and-deal-talk-builds/",{"id":109,"title":110,"source":111,"logo":19,"time":112},225254,"Biopharmaceutical Sector Sees Surge in Deals Ahead of J.P. Morgan Healthcare Conference","https://www.geneonline.com/biopharmaceutical-sector-sees-surge-in-deals-ahead-of-j-p-morgan-healthcare-conference/","7天前",{"id":114,"title":115,"source":116,"logo":47,"time":69},225239,"JPMorgan conference says healthcare market rebounds as rates, M&A, AI drive growth - CHOSUNBIZ","https://biz.chosun.com/en/en-science/2026/01/13/UTLQDP2RL5GKTO5CRECZ7M5PSU/",{"id":118,"title":119,"source":120,"logo":21,"time":74},225238,"#JPM26 live blog day 1: Deal flow is small to start off 2026, but companies say they're looking around","https://endpoints.news/jpm26-day-1-at-the-jp-morgan-healthcare-conference/",{"id":122,"title":123,"source":124,"logo":10,"time":69},225237,"Today at JPM: M&A simmers but no sparks, moving on from MFN, and gene therapy's MAHA moment","https://firstwordpharma.com/story/7061732",{"id":126,"title":127,"source":128,"logo":37,"time":69},225236,"JPM 2026 Archives","https://www.geneonline.com/category/conferences/jpm-2026/",{"id":130,"title":131,"source":132,"logo":45,"time":74},225242,"JPMorgan Healthcare Conference Won’t Limit Deals to Just Biopharma","https://www.bloomberg.com/news/newsletters/2026-01-12/jpmorgan-healthcare-conference-deals-m-a-could-include-ai-life-sciences",{"id":134,"title":135,"source":136,"logo":11,"time":69},225241,"JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year","https://www.biopharmadive.com/news/jpm26-china-biotech-pfizer-obesity-bristol-sarepta-elevidys-sales/809320/",{"id":138,"title":139,"source":140,"logo":5,"time":69},225240,"Pfizer Targets Obesity Treatments as China’s Biotech Influence Grows","https://www.geneonline.com/pfizer-targets-obesity-treatments-as-chinas-biotech-influence-grows/",{"id":142,"title":143,"source":144,"logo":33,"time":69},225246,"The JPM week social map: Who you’ll see, where you’ll see them","https://sfstandard.com/2026/01/12/jpm-week-social-map-who-ll-see-ll-see/",{"id":146,"title":147,"source":148,"logo":5,"time":69},225245,"Fasken in San Francisco for the JP Morgan Healthcare Conference Week","https://www.fasken.com/en/news/2026/01/fasken-in-san-francisco-for-the-jp-morgan-healthcare-conference-week",{"id":150,"title":151,"source":152,"logo":41,"time":69},225244,"JPM 2026: Year kicks off with biopharma Q4 revenue and guidance","https://www.bioworld.com/articles/727865-jpm-2026-year-kicks-off-with-biopharma-q4-revenue-and-guidance",{"id":154,"title":155,"source":156,"logo":26,"time":74},225243,"AI, Medicaid cuts and payer no-shows: What to watch at JPM 2026","https://www.fiercehealthcare.com/finance/ai-medicaid-cuts-and-payer-no-shows-3-things-watch-jpm-2026",{"id":158,"title":159,"source":160,"logo":29,"time":112},226831,"Healthcare dealmakers head to San Francisco hoping for megamergers in 2026","https://www.reuters.com/business/healthcare-pharmaceuticals/healthcare-dealmakers-head-san-francisco-hoping-megamergers-2026-2026-01-09/",{"id":162,"title":163,"source":164,"logo":15,"time":112},226832,"No More Confusion for Pharmaceutical Makers: M&A Volume Surges 124% in 2025, Giants Sweep Up Innovative Drug Assets","https://news.futunn.com/en/post/67187927/no-more-confusion-for-pharmaceutical-makers-m-a-volume-surges",{"id":166,"title":159,"source":167,"logo":30,"time":112},226833,"https://finance.yahoo.com/news/healthcare-dealmakers-head-san-francisco-161902747.html",{"id":169,"title":170,"source":171,"logo":17,"time":69},225229,"JPM26, Day 1: Lilly, Nvidia expand AI team-up; Takeda R&D head talks lack of deal announcements","https://www.fiercebiotech.com/biotech/fierce-biotechs-jpm26-tracker-day-1",{"id":173,"title":174,"source":175,"logo":5,"time":176},226834,"At JPM26, policy and politics will loom large for Pharma as biotech sees the sun","https://www.pharmalive.com/at-jpm26-policy-and-politics-will-loom-large-for-pharma-as-biotech-sees-the-sun/","8天前",{"id":178,"title":179,"source":180,"logo":13,"time":69},225231,"JP Morgan 2026: Eight Companies' Clinical Milestones across tRNA Medicines, Immune Reset, and Oncology","https://www.geneonline.com/jp-morgan-2026-eight-companies-clinical-milestones-across-trna-medicines-immune-reset-and-oncology/",{"id":182,"title":183,"source":184,"logo":18,"time":69},225473,"JPM 26: Day 1 – drug prices and policy changes drive the agenda","https://finance.yahoo.com/news/jpm-26-day-1-drug-105917407.html",{"id":186,"title":187,"source":188,"logo":13,"time":69},225230,"Regulatory Changes and U.S. Drug Pricing Models Discussed at JPM 2026 Opening Day","https://www.geneonline.com/regulatory-changes-and-u-s-drug-pricing-models-discussed-at-jpm-2026-opening-day/",{"id":190,"title":191,"source":192,"logo":5,"time":69},225235,"The Hong Kong stock market's innovative pharmaceuticals sector has seen an upward trend as the 'JPM Conference,' often referred to as the 'Pharma Spring Festival,' officially kicks off, with Chinese innovative pharmaceutical companies set to make a collec","https://news.futunn.com/en/post/67288629/the-hong-kong-stock-market-s-innovative-pharmaceuticals-sector-has",{"id":194,"title":195,"source":196,"logo":12,"time":69},225234,"JPM 2026, Day 1: Advocate sees greater cost-savings from merger","https://www.modernhealthcare.com/providers/mh-jpm-2026-live-updated/",{"id":198,"title":199,"source":200,"logo":43,"time":112},225476,"Healthy Returns: What to expect from pharma at the JPM conference","https://www.cnbc.com/2026/01/09/healthy-returns-what-to-expect-from-pharma-at-the-jpm-conference.html",{"id":202,"title":203,"source":204,"logo":25,"time":69},225233,"JPM26, Day 1: Advocate Health, MGB tout integrations; Waystar rolls out agentic AI","https://www.fiercehealthcare.com/health-tech/jpm26-day-1",{"id":206,"title":207,"source":208,"logo":38,"time":74},225475,"Why the JP Morgan conference is important — but not make-or-break","https://www.statnews.com/2026/01/11/jp-morgan-conference-2026-adam-feuerstein-advice-biotech/",{"id":210,"title":211,"source":212,"logo":13,"time":69},225232,"From Main Venue Presentations to Strategic Partnering, Taiwan’s Biotech Sector Makes Its Mark in JPM 2026","https://www.geneonline.com/from-main-venue-presentations-to-strategic-partnering-taiwans-biotech-sector-makes-its-mark-in-jpm-2026/",{"id":214,"title":215,"source":216,"logo":16,"time":69},225474,"J.P. Morgan Healthcare Conference 2026 kicks off in San Francisco, packing hotels and bringing big business","https://abc7news.com/post/jp-morgan-healthcare-conference-2026-kicks-off-san-francisco-packing-hotels-bringing-big-business/18393704/",{"id":218,"title":219,"source":220,"logo":28,"time":69},226828,"#JPM2026 Day One Update","https://www.evaluate.com/thought-leadership/jpm2026-day-one-update/",{"id":222,"title":223,"source":224,"logo":44,"time":74},226829,"Despite few big announcements at JPM, biotech investors optimistic","https://cen.acs.org/pharmaceuticals/drug-development/Despite-few-big-announcements-JPM/104/web/2026/01",{"id":226,"title":227,"source":228,"logo":14,"time":69},226824,"JPM deals, policy outlook and trends in FDA approvals","https://www.biocentury.com/article/658052/jpm-deals-policy-outlook-and-trends-in-fda-approvals",{"id":230,"title":231,"source":232,"logo":48,"time":69},226901,"#JPM26 live blog day 2: Novo’s plans in the clinic, AI talent wars and Nobel winner Fred Ramsdell","https://endpoints.news/jpm26-day-2-at-the-jp-morgan-healthcare-conference/",{"id":234,"title":235,"source":236,"logo":42,"time":69},226825,"Highlights from Day 1 at JPM Healthcare 2026","https://www.pharmtech.com/shorts/highlights-from-day-1-at-jpm-healthcare-2026",{"id":238,"title":239,"source":240,"logo":12,"time":176},225259,"JPM 2026: What to know about the San Francisco conference","https://www.modernhealthcare.com/providers/mh-2026-jpm-healthcare-conference/",{"id":242,"title":243,"source":244,"logo":13,"time":69},226826,"J.P. Morgan Healthcare Conference Focuses on Financial Strategies Over Patient Care","https://www.geneonline.com/j-p-morgan-healthcare-conference-focuses-on-financial-strategies-over-patient-care/",{"id":246,"title":247,"source":248,"logo":49,"time":176},225258,"Pharma Deals on the Rise as Industry Shakes Off Trump Anxiety","https://www.bloomberg.com/news/articles/2026-01-09/pharma-deals-on-the-rise-as-industry-shakes-off-trump-anxiety",{"id":250,"title":251,"source":252,"logo":46,"time":69},226827,"JPM Day 1: Obesity Front-and-Center, Q4 Sales Beats","https://www.biospace.com/business/jpm-day-1-obesity-front-and-center-q4-sales-beats",{"id":254,"title":255,"source":256,"logo":35,"time":112},225264,"Mega-Mergers Await: Healthcare M&A Set to Surge Amid Relaxed Regulations","https://www.devdiscourse.com/article/health/3765459-mega-mergers-await-healthcare-ma-set-to-surge-amid-relaxed-regulations",{"id":258,"title":159,"source":259,"logo":23,"time":112},225263,"https://www.msn.com/en-us/money/markets/healthcare-dealmakers-head-to-san-francisco-hoping-for-megamergers-in-2026/ar-AA1TUdGT?ocid=finance-verthp-feeds",{"id":261,"title":262,"source":263,"logo":5,"time":176},225262,"Top Biotech Players REGN, INCY, PTCT Among Participants At J.P.Morgan Healthcare Conference 2026","https://www.rttnews.com/3609103/top-biotech-players-regn-incy-ptct-among-participants-at-j-p-morgan-healthcare-conference-2026.aspx",{"id":265,"title":266,"source":267,"logo":40,"time":112},225261,"Where to go and where to hide during the big JPM biotech conference in San Francisco","https://www.bizjournals.com/sanfrancisco/news/2026/01/09/jp-morgan-healthcare-conference-guide.html",{"id":269,"title":93,"source":270,"logo":36,"time":69},226830,"https://www.barrons.com/articles/biotech-stocks-chase-conference-b9cab762?gaa_at=eafs&gaa_n=AWEtsqcr4pRGQDETTfQW2aedjosMdTE-EMunxsDGtevX1qzbCSS5roIdbyYW&gaa_ts=696670c2&gaa_sig=qdKQ-sUv4Lu5lOSavepmmYjJ9A8GDZR_0dP5_bms7icubn9VYHl3qZ1Wk0MQoZELqG2YmAJrxpzV6Va0lQ_zXg%3D%3D",{"id":272,"title":273,"source":274,"logo":27,"time":176},225260,"During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media","https://www.tradingview.com/news/eqs:6e1107f58094b:0-during-j-p-morgan-healthcare-week-biotech-showcase-provides-private-and-micro-to-mid-cap-public-company-executives-one-stop-access-to-investors-pharma-partners-and-media/","#74cb0cff","#74cb0c4d",1768678276511]